Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1988-03-30
1991-06-11
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
424 78, 424432, 424484, 424485, 424486, 424487, 424488, A61K 900
Patent
active
050230824
ABSTRACT:
The present invention pertains to biodegradable sustained-release composins capable of achieving the sustained release of a pharmaceutical or other agent. The compositions can be formed into implant devices which may be used to treat a wide variety of diseases and conditions. The implants are especially useful in treating diseases such as periodontal disease which require prolonged drug release.
REFERENCES:
patent: 3921636 (1975-11-01), Zaffaroni
patent: 3933025 (1976-01-01), Whitaker et al.
patent: 4169885 (1979-10-01), Raaf
patent: 4277364 (1981-07-01), Shasha
patent: 4279812 (1981-07-01), Cioca
patent: 4307717 (1981-12-01), Hymes et al.
patent: 4344857 (1982-08-01), Shasha
patent: 4349530 (1982-09-01), Royer
patent: 4359483 (1982-11-01), Kaetsu et al.
patent: 4442655 (1984-04-01), Stroetmann
patent: 4492684 (1985-01-01), Goosen et al.
patent: 4517006 (1985-05-01), Drake et al.
patent: 4568536 (1986-02-01), Kronenthal et al.
patent: 4569837 (1986-02-01), Suzuki et al.
patent: 4675381 (1987-06-01), Bichon
patent: 4678516 (1987-07-01), Alderman
patent: 4703108 (1987-10-01), Silver et al.
patent: 4794002 (1988-12-01), Henis et al.
patent: 4803075 (1989-02-01), Wallace et al.
Friedman Michael
Soskolne Aubrey
Steinberg Doron
Page Thurman K.
Yissum Research Development Company of the Hebrew University of
LandOfFree
Sustained-release pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained-release pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained-release pharmaceutical compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-781769